期刊文献+

4种β-内酰胺类抗生素延长输注对重症感染的药效学研究 被引量:11

Pharmacodynamics of prolonged dosing regimens of four β-lactam antibiotics against severe infection
下载PDF
导出
摘要 目的:评价4种β-内酰胺类抗生素延长输注给药方案对重症感染的药效学。方法:测定医院明确为重症感染的120株革兰阴性杆菌的MIC,应用10 000例蒙特卡罗模拟分析头孢他啶、哌拉西林他唑巴坦、亚胺培南及美罗培南传统输注30min及延长输注1、2、3、4、5h的药效学达标概率。结果:对于传统30min输注方案,没有一种抗生素能获得90%以上的累积反应分数(CFR)。缩短给药间隔、增加每次给药剂量、延长输注时间均能增加CFR。对于4种抗生素延长输注1、2、3、4、5h的给药,哌拉西林他唑巴坦4.5g q8h的给药方案随着输注时间延长,获得的CFR相应逐渐增加。头孢他啶2g q6h,亚胺培南0.5g q6h、1g q6h,美罗培南0.5g q6h延长输注至3h时,获得最高的CFR,分别为84.38%、78.50%、87.03%、81.53%。而头孢他啶2g q8h,哌拉西林他唑巴坦4.5g q6h,亚胺培南1g q8h,美罗培南1g q8h、2g q8h延长输注至4h时,获得最高的CFR,分别为83.12%、89.94%、83.87%、82.29%、86.98%。结论:由于重症感染的耐药率较高,常规给药方案不能获得理想的药效学。延长输注时间能增加药效学达标概率,3h或者4h可能为最佳输注时间。 AIM: To evaluate pharmacodyna- mic profiling of dosage regimens of four β-lactam antibiotics against severe infection. METHODS: Minimum inhibitory concentrations for 120 Gram-negative bacteria from patients managed in intensive care unit were determined. A 10 000- subject Monte Carlo simulation was performed to calculate pharmacodynamic target attainment for traditional infusion and prolonged dosing regimens of 1,2,3,4 h and 5 h infusion of ceftaz- idime, piperacillin-tazobactam, imipenem and meropenem. RESULTS:No regimen of traditional infusion achieved cumulative fraction of response (CFR) of greater than 90%. Increasing doses, increasing frequencies and prolonging infusion time regimens achieved higher CFR. The results of prolonged infusion of 1,2,3,4 h and 5 h were as follows. When the infusion time of piperacil- lin-tazobactam 4.5 g q8 h was gradually pro- longed,the highest CFR was achieved by a 5 h prolonged infusion. However, the highest CFR was achieved by 3 h prolonged infusion for dos- age regimens of ceftazidime 2 g q6 h,imipenem 0.5 g q6 h,1 g q6 h and meropenem 0.5 g q6 h, 84.38%,78.50%,87.03%, 81.53%, respective- ly. The highest CFR was achieved by 4 h pro- longed infusion for dosage regimens of ceftazi- dime 2 g q8 h, piperacillin-tazobactam 4.5 g q6 h,imipenem 1 g q8 h and meropenem 1 g q8 h, 2 g q8 h, 83.12% ,89.94% ,83.87% ,82.29% ,86. 98~, respectively. CONCLUSION: As a result of high resistance rate in intensive care unit, no regimen attains optimal bactericidal exposure a- gainst severe infection. Prolonged infusion regi- mens improve pharmacodynamic target attain- ment. 3 h or 4 h is probably optimal infusion time.
出处 《中国临床药理学与治疗学》 CAS CSCD 2015年第1期51-55,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 宁波市自然科学基金(2012A610231)
关键词 蒙特卡罗模拟 药效学 重症感染 延长输注 monte carlo simulation pharma-codynamics severe infection prolonged infusion
  • 相关文献

参考文献14

二级参考文献26

共引文献86

同被引文献108

  • 1抗菌药物临床应用指导原则[J].中国临床药学杂志,2005,14(3). 被引量:82
  • 2陈灏珠,林果为.实用内科学[M].13版.北京:人民卫生出版社,2010:2044. 被引量:54
  • 3卫生部抗生素临床药理基地.抗菌药物临床研究指导原则.中国临床药理学杂志,1987,2:189-191. 被引量:25
  • 4国家食品药品监督管理局药品安全监管司,国家药品不良反应中心编.药品不良反应报告和监测工作手册[S].2005:46. 被引量:12
  • 5Ludwig E, Konkoly-Thege M, Kuti JL, et al. Optimising antibiotic dosing regimens based on pharmacodynamic target attainment against Pseudomonas aeruginosa collected in Hungarian hospitals [ J]. Int J Antimicrob Agents ,2007,30 (5) :452- 457. 被引量:1
  • 6Crandon JL, Nicolau DP. Pharrnacodynamic approaches to optimizing beta-lactam therapy[ J]. Crit Care Clin,2011,27 ( 1 ) : 77-93. 被引量:1
  • 7Knaus WA, Draper EA, Wagner DP, et al. APACHE H : a severity of disease classification system[ J]. Crit Care Med, 1985, 13(10) :818-829. 被引量:1
  • 8Turnidge JD. The Pharmacodynanfics of beta-lactams [ J ]. Clin Infect Dis, 1998,27 : 10-22. 被引量:1
  • 9Arnold A, Brouse SD, Pitcher WD, et al. Empiric therapy for gram-negative pathogens in nosocomial and health care-associated pneumonia: starting with the end in mind[J]. Intensive Care Med, 2010, 25(5): 259 -270. 被引量:1
  • 10De Ryke CA, Kuti JL, Nicolau DP. Pharmacodynamic target attainment of six -lactams and two fluoroquino- lones against Pseudomonas aeruginosa, A cinetobac terbaumannii, E scheri chiacoli and K lebsi ella spe- cies collected from United States intensive care unit sin 2004 [ J ]. Pharmacotherapy, 2007, 27 (3) : 333-342. 被引量:1

引证文献11

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部